BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21856416)

  • 1. Quantitative analysis of rate and extent of tolerance of biomarkers: application to nicotinic acid-induced changes in non-esterified fatty acids in rats.
    Ahlström C; Peletier LA; Gabrielsson J
    Eur J Pharm Sci; 2011 Oct; 44(3):250-64. PubMed ID: 21856416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.
    Ahlström C; Kroon T; Peletier LA; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2013 Dec; 40(6):623-38. PubMed ID: 24114415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions.
    Ahlström C; Peletier LA; Jansson-Löfmark R; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):1-24. PubMed ID: 21046209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats.
    Ahlström C; Peletier LA; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2013 Aug; 40(4):497-512. PubMed ID: 23824920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of nicotinic acid to induce sustained low plasma nonesterified fatty acids in feed-restricted Holstein cows.
    Pires JA; Grummer RR
    J Dairy Sci; 2007 Aug; 90(8):3725-32. PubMed ID: 17638983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response-time modelling: Second-generation turnover model with integral feedback control.
    Andersson R; Jirstrand M; Peletier L; Chappell MJ; Evans ND; Gabrielsson J
    Eur J Pharm Sci; 2016 Jan; 81():189-200. PubMed ID: 26529383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments.
    Andersson R; Kroon T; Almquist J; Jirstrand M; Oakes ND; Evans ND; Chappel MJ; Gabrielsson J
    J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):203-222. PubMed ID: 28224315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid.
    Tapani S; Almquist J; Leander J; Ahlström C; Peletier LA; Jirstrand M; Gabrielsson J
    J Pharm Sci; 2014 Aug; 103(8):2571-84. PubMed ID: 24986056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel minimal model to describe non-esterified fatty acid kinetics in Holstein dairy cows.
    Boston RC; Roche JR; Ward GM; Moate PJ
    J Dairy Res; 2008 Feb; 75(1):13-8. PubMed ID: 17922935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenging the dose-response-time data approach: Analysis of a complex system.
    Andersson R; Jirstrand M; Almquist J; Gabrielsson J
    Eur J Pharm Sci; 2019 Feb; 128():250-269. PubMed ID: 30453011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.
    Mandema JW; Wada DR
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antilipolytic and lipolytic effects of administering free or ruminally protected nicotinic acid to feed-restricted Holstein cows.
    Pescara JB; Pires JA; Grummer RR
    J Dairy Sci; 2010 Nov; 93(11):5385-96. PubMed ID: 20965354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia.
    Vega GL; Cater NB; Meguro S; Grundy SM
    Am J Cardiol; 2005 Jun; 95(11):1309-13. PubMed ID: 15904634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a compartmental model to describe non-esterified fatty acid kinetics in Holstein dairy cows.
    Moate PJ; Roche JR; Chagas LM; Boston RC
    J Dairy Res; 2007 Nov; 74(4):430-7. PubMed ID: 17651516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of plasma NEFA concentration by nicotinic acid enhances the response to insulin in feed-restricted Holstein cows.
    Pires JA; Pescara JB; Grummer RR
    J Dairy Sci; 2007 Oct; 90(10):4635-42. PubMed ID: 17881684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute dose-dependent disposition studies of nicotinic acid in rats.
    Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ
    Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nicotinic acid on plasma glucose concentration in normal individuals.
    Landau C; Chen YD; Skowronski R; Hollenbeck CB; Jaspan JB; Reaven GM
    Horm Metab Res; 1992 Sep; 24(9):424-8. PubMed ID: 1358776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnover modeling of non-esterified fatty acids in rats after multiple intravenous infusions of nicotinic acid.
    Isaksson C; Gabrielsson J; Wallenius K; Peletier LA; Toreson H
    Dose Response; 2009 Apr; 7(3):247-69. PubMed ID: 19809543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats.
    Ekblom M; Hammarlund-Udenaes M; Paalzow L
    J Pharmacol Exp Ther; 1993 Jul; 266(1):244-52. PubMed ID: 8331561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.